Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

NCT05232916

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • City of Hope - Cancer Center Phoenix Goodyear, Arizona, United States
  • Tucson Medical Center HealthCare Tucson, Arizona, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
View all 179 locations
View Trial Details
Recruiting

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

NCT04434040

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • University of Chicago Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
  • University of Chicago Medical Center for Advanced Care Orland Park Orland Park, Illinois, United States
View Trial Details

Related conditions